Nintedanib and Weekly Docetaxel in Lung Adenocarcinoma

Clinical trial NCT02668393 · COMPLETED

Trial details

NCT number: NCT02668393
Sponsor: Boehringer Ingelheim
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2016-03-07
Primary completion: 2019-11-27
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.